US Broker Ratings

Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking 21% Potential Upside for Healthcare Investors

Stevanato Group S.p.A. (NYSE: STVN), an Italian powerhouse in the healthcare sector, presents a compelling opportunity for investors with its diverse array of offerings in the..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 15.58% Potential Upside in Biotechnology

For investors seeking promising opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) stands out with its robust portfolio and promising growth trajectory. Based out of..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Buy Ratings and 8.14% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) stands out in the healthcare sector, specifically within the medical devices industry, for its innovative contributions to organ transplant therapy. With..

Alcon Inc. (ALC) Stock Analysis: Exploring a Promising 20.91% Upside Potential

Alcon Inc. (NYSE: ALC), a global leader in eye care, is catching the attention of investors with a notable 20.91% potential upside. Operating in the healthcare..

Vaxcyte, Inc. (PCVX) Stock Analysis: Examining a Potential 78% Upside in the Biotech Frontier

Vaxcyte, Inc. (NASDAQ: PCVX), a pioneering player in the biotechnology sector, stands at the forefront of vaccine innovation, with a market capitalization of $9.1 billion. Specializing..

HealthEquity, Inc. (HQY) Investor Outlook: Analyst Ratings Signal a Promising 23.87% Potential Upside

HealthEquity, Inc. (HQY), a prominent player in the healthcare information services sector, is capturing the attention of investors with its robust growth metrics and impressive analyst..

Corcept Therapeutics (CORT): Exploring the 26% Upside Potential in the Biotech Sector

Corcept Therapeutics Incorporated (CORT) is drawing significant attention in the biotech investment landscape with its compelling growth potential and strategic positioning. As a biopharmaceutical company operating..

BioNTech SE (BNTX) Stock Analysis: Navigating Growth Amidst a 15.99% Upside Potential

BioNTech SE (NASDAQ: BNTX), a stalwart in the biotechnology sector, has been at the forefront of developing innovative immunotherapies. Known primarily for its mRNA-based COVID-19 vaccine,..

Agilent Technologies, Inc. (A) Investor Outlook: Analyzing a 16.30% Potential Upside in the Diagnostics Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 30% Potential Upside with Strong Buy Ratings

AstraZeneca PLC (AZN), a leading giant in the healthcare sector, has been catching the eye of investors with its promising potential upside of 30.63%. As a..

AptarGroup, Inc. (ATR) Stock Analysis: A 33.54% Potential Upside Beckons Investors

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, is garnering significant attention from investors looking to capitalize on its promising growth potential. With..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and a 17.28% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, is making waves in the healthcare industry with its robust portfolio of pharmaceutical products..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 20% Potential Upside with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its innovative diagnostics and research solutions. Based in..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Potential with a 17.97% Return on Equity

Inspire Medical Systems, Inc. (NASDAQ: INSP), a notable player in the healthcare sector, specializes in pioneering medical devices designed to tackle obstructive sleep apnea (OSA). With..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Exploring a Potential 61.45% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) is making waves in the biotechnology sector with its ambitious focus on developing breakthrough treatments for cancer. The company’s lead candidate,..

iRhythm Holdings, Inc. (IRTC): Analyst Ratings Signal a Promising 43% Upside for Investors

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its robust growth potential in the healthcare sector, specifically within the medical devices industry. The San..

Oscar Health, Inc. (OSCR)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: Biotech Growth with 51% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands as a noteworthy player in the biotechnology sector, carving a niche in the healthcare industry with its focus on novel muscle..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech with 76% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, presents an intriguing investment opportunity with a potential upside of 76.72%, according to analyst..

Qiagen N.V. (QGEN) Stock Analysis: Exploring the 5.98% Potential Upside for Investors

Qiagen N.V. (NASDAQ: QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is headquartered in Venlo, the Netherlands. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds